KATP channel activator (Glucox Biotech)

N/A

Report date: 2025/03/20 15:45:26
NME

Base Information

Drug NameKATP channel activator (Glucox Biotech)
Drug Alias NameATP-sensitive potassium channel activator (Glucox Biotech AB)ATP-sensitive potassium channel activator (Swedish Orphan Biovitrum)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel agonists
TargetsPotassium channel
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSwedish Orphan Biovitrum Ab (Publ)
China Registration ClassN/A

Develop Information

Active CompaniesGlucox Biotech AB
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A